Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Novartis AG ADR (NYSE: NVS) closed at $98.59 in the last session, down -0.58% from day before closing price of $99.17. In other words, the price has decreased by -$0.58 from its previous closing price. On the day, 1.05 million shares were traded. NVS stock price reached its highest trading level at $99.45 during the session, while it also had its lowest trading level at $98.56.
Ratios:
We take a closer look at NVS’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 13.76 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 13.07. For the most recent quarter (mrq), Quick Ratio is recorded 0.90 and its Current Ratio is at 1.11. In the meantime, Its Debt-to-Equity ratio is 0.74 whereas as Long-Term Debt/Eq ratio is at 0.59.
On September 11, 2024, BofA Securities Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $135 to $130.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 12 ’24 when Kowalski Robert William bought 6,566 shares for $111.72 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NVS now has a Market Capitalization of 199168557056 and an Enterprise Value of 215540039680. As of this moment, Novartis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 11.50, and their Forward P/E ratio for the next fiscal year is 12.01. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.63. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.97 while its Price-to-Book (P/B) ratio in mrq is 4.55. Its current Enterprise Value per Revenue stands at 4.316 whereas that against EBITDA is 10.271.
Stock Price History:
Over the past 52 weeks, NVS has reached a high of $120.92, while it has fallen to a 52-week low of $92.35. The 50-Day Moving Average of the stock is -9.08%, while the 200-Day Moving Average is calculated to be -7.46%.
Shares Statistics:
According to the various share statistics, NVS traded on average about 1.13M shares per day over the past 3-months and 1010000 shares per day over the past 10 days. A total of 2.00B shares are outstanding, with a floating share count of 1.96B. Insiders hold about 0.00% of the company’s shares, while institutions hold 6.77% stake in the company. Shares short for NVS as of 1732838400 were 4491878 with a Short Ratio of 3.99, compared to 1730332800 on 4756322. Therefore, it implies a Short% of Shares Outstanding of 4491878 and a Short% of Float of 0.22.
Dividends & Splits
The forward annual dividend rate for NVS is 3.74, which was 3.919 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.039518The stock’s 5-year Average Dividend Yield is 3.62.
